Observational Study: Oxygen Therapy Monitoring in COPD Patients Using Connected Devices.

Status: Recruiting
Location: See all (24) locations...
Study Type: Observational
SUMMARY

Background : Long-term oxygen therapy is prescribed for patients with severe COPD. The aim of oxygen therapy is to administer oxygen at a concentration level higher than that of ambient air, in order to treat or prevent the symptoms and manifestations of arterial hypoxemia; this therapy can be applied either in an acute situation or as a long-term treatment, in cases of stabilized severe chronic hypoxemia. Currently, pneumologists do not have the possibility, between 2 consultations spaced several months apart, to measure the patient's compliance with the treatment (adherence to oxygen therapy) nor the respect of the prescribed dosage (O2 flow and duration). In addition to the patient's adherence to the treatment, the specialist does not have the possibility to assess the patient's physical activity (walking ...). This observational study is a e-health, prospective, multicenter study conducted in France under the control of pneumologists. The main objective of this study is to evaluate the adherence to oxygen therapy in real life, and its evolution, in COPD patients justifying a long term oxygen therapy in stable state.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• COPD patients who require the initiation of a long term oxygen therapy.

• Patient agreeing to use a connected watch and a TeleOx for the remote monitoring of their parameters and physical activity.

• Non-smoker, ex-smoker, or patient agreeing to stop smoking.

• Life expectancy greater than 6 months.

• Signed informed consent form,

• Subject affiliated to a health insurance system, or is a beneficiary.

Locations
Other Locations
France
CHIAP
RECRUITING
Aix-en-provence
Cabinet privé
NOT_YET_RECRUITING
Antibes
Cabinet libéral
NOT_YET_RECRUITING
Avignon
CH Avignon
NOT_YET_RECRUITING
Avignon
CH Blois
NOT_YET_RECRUITING
Blois
CH Bligny
NOT_YET_RECRUITING
Briis-sous-forges
CH Cannes
NOT_YET_RECRUITING
Cannes
Hôpital Percy
NOT_YET_RECRUITING
Clamart
Cabinet libéral
NOT_YET_RECRUITING
Foix
Cabinet libéral
NOT_YET_RECRUITING
Le Puy-en-velay
CH Libourne
NOT_YET_RECRUITING
Libourne
Hôpital La Louvière
NOT_YET_RECRUITING
Lille
Centre médical Parot
NOT_YET_RECRUITING
Lyon
AP-HM Hopital nord
NOT_YET_RECRUITING
Marseille
Hôpital d'Instruction des Armées Laveran
NOT_YET_RECRUITING
Marseille
Hôpital Saint Joseph
NOT_YET_RECRUITING
Marseille
GHI Le Raincy
NOT_YET_RECRUITING
Montfermeil
CHRU Nancy-Université de Lorraine
NOT_YET_RECRUITING
Nancy
Polyclinique des fleurs
NOT_YET_RECRUITING
Ollioules
CH de Perpignan
NOT_YET_RECRUITING
Perpignan
Pneumology practice
NOT_YET_RECRUITING
Perpignan
CHU de Bordeaux
NOT_YET_RECRUITING
Pessac
Cabinet libéral
NOT_YET_RECRUITING
Poissy
MGEN
NOT_YET_RECRUITING
Sainte-feyre
Contact Information
Primary
Anne-Laure Sérandour
al.serandour@slbpharma.com
+33 2 99 12 19 62
Backup
Laurent Pupin
l.pupin@vivisol.fr
+33 1 64 39 11 12
Time Frame
Start Date: 2023-01-27
Estimated Completion Date: 2025-01-27
Participants
Target number of participants: 250
Sponsors
Leads: Vivisol
Collaborators: Slb Pharma

This content was sourced from clinicaltrials.gov